Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
   21  Cardiovascular agents
   22  Respiratory organ agents
   23  Digestive organ agents
     231  Antidiarrheals, intestinal regulators
     232  Peptic ulcer agents
       2321  Methylmethionines
       2322  Glutamines
       2323  Azulenes
       2324  Herbal medicines
       2325  H2 blockers
         D00295  Cimetidine (JP16/USP/INN)
         D00673  Ranitidine hydrochloride (JP16/USP)
         D00318  Famotidine (JP16/USP/INN)
         D00440  Nizatidine (JP16/USP/INN)
         D01467  Roxatidine acetate hydrochloride (JP16/USAN)
         D01131  Lafutidine (JP16/INN)
A02BA01
A02BA02
A02BA03
A02BA04
A02BA06
A02BA08
       2329  Others
     233  Stomachics and digestives
     234  Antacids
     235  Purgatives, clysters
     236  Cholagogues
     237  Gastrointestinal agents and combinations
     239  Miscellaneous
   24  Hormones
   25  Urogenital and anal organ agents
   26  Epidermides
   27  Dental preparations
   29  Other agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: September 20, 2014
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version